This site uses cookies, tags, and tracking settings to store information to help give you the very best browsing experience. Dismiss this warning

The Six-Minute Walk Test as a Measure of Health in Breast Cancer Patients

Click name to view affiliation

Noelia Galiano-Castillo
Search for other papers by Noelia Galiano-Castillo in
Current site
Google Scholar
PubMed
Close
,
Manuel Arroyo-Morales
Search for other papers by Manuel Arroyo-Morales in
Current site
Google Scholar
PubMed
Close
,
Angélica Ariza-Garcia
Search for other papers by Angélica Ariza-Garcia in
Current site
Google Scholar
PubMed
Close
,
Carmen Sánchez-Salado
Search for other papers by Carmen Sánchez-Salado in
Current site
Google Scholar
PubMed
Close
,
Carolina Fernández-Lao
Search for other papers by Carolina Fernández-Lao in
Current site
Google Scholar
PubMed
Close
,
Irene Cantarero-Villanueva
Search for other papers by Irene Cantarero-Villanueva in
Current site
Google Scholar
PubMed
Close
, and
Lydia Martín-Martín
Search for other papers by Lydia Martín-Martín in
Current site
Google Scholar
PubMed
Close
Restricted access

This study examined the relationship between the 6-min walk test (6MWT) and fitness, psychological and physiologic states, quality of life, cancer-related symptoms, and body composition of 87 women with breast cancer. The assessment included the 6MWT and evaluations of Cancer Quality of Life (EORTC C-30 and EORTC BR-23), cognitive performance (Trail Making Test), the Hospital Anxiety and Depression Scale, body composition, health-related fitness (abdominal test, multiple sit-to-stand test, trunk dynamometry), and pain (Brief Pain Inventory). We observed the following correlations: moderate between 6MWT and pain interference; modest for cognitive and social functioning and the multiple sit-to-stand test; fair for several items on the Cancer Quality of Life, for anxiety, lean body mass, trunk dynamometry and pain intensity; and weak for role functioning, loss of appetite, cognitive performance and depression. Thus, the 6MWT could be used as a measure of the major components of global health in women with breast cancer.

Galiano-Castillo, Arroyo-Morales, Ariza-Garcia, Fernández-Lao, and Cantarero-Villanueva are with the Physical Therapy Department, Instituto Investigación Biosanitaria (IBIS Granada), Universidad de Granada, Granada, Spain. Ariza-Garcia is also with University Hospital San Cecilio, Health Andalusian Service, Granada, Spain. Sánchez-Salado is with the Breast Oncology Unit, Hospital Virgen de las Nieves, Granada, Spain. Martín-Martín is with the Department of Physical Therapy, University of Granada, Granada, Spain.

Address author correspondence to Lydia Martín-Martín at lydia@ugr.es.
  • Collapse
  • Expand